Unravelling the role of melanogenesis in melanoma: oncogenic crosstalk and therapeutic prospects
- 23 September 2025
- journal article
- review article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-24
Abstract
No abstract availableKeywords
This publication has 151 references indexed in Scilit:
- BCL-2 protein family: attractive targets for cancer therapyApoptosis, 2022
- NF‐κB signaling in inflammation and cancerMedcomm, 2021
- Role of PI3K/AKT pathway in cancer: the framework of malignant behaviorMolecular Biology Reports, 2020
- Roles of UVA radiation and DNA damage responses in melanoma pathogenesisEnvironmental and Molecular Mutagenesis, 2018
- Photoprotection versus photodamage: updating an old but still unsolved controversy about melaninPolymer International, 2016
- CDKN2a mutation‐negative melanoma families have increased risk exclusively for skin cancers but not for other malignanciesInternational Journal of Cancer, 2015
- MITF in melanoma: mechanisms behind its expression and activityCellular and Molecular Life Sciences, 2014
- Targeting RAS/RAF/MEK/ERK signaling in metastatic melanomaIUBMB Life, 2013
- Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cellsInternational Journal of Cancer, 2008
- A second tyrosinase‐related protein, TRP‐2, is a melanogenic enzyme termed DOPAchrome tautomerase.The EMBO Journal, 1992